Urenco Finance N.V. Urenco Finance N.V. Result of Tender Offer (3898N)

TIDM44ZP

RNS Number : 3898N

Urenco Finance N.V.

17 January 2019

URENCO Finance N.V. Announces Results of its Tender Offer in respect of its

EUR750,000,000 2.50 per cent. Notes due 2021

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT

17 January 2019. URENCO Finance N.V. (the Company) announces today the results of its invitation to holders of its EUR750,000,000 2.50 per cent. Notes due 2021 (ISIN: XS1032164607) (the Notes) to tender their Notes for purchase by the Company for cash (the Offer).

The Offer was announced on 9 January 2019, and was made on the terms and subject to the conditions contained in the tender offer memorandum dated 9 January 2019 (the Tender Offer Memorandum) prepared by the Company. Capitalised terms used in this announcement but not defined have the meanings given to them in the Tender Offer Memorandum.

The Expiration Deadline for the Offer was 5.00 p.m. (CET) on 16 January 2019.

As at the Expiration Deadline, EUR215,600,000 in aggregate nominal amount of the Notes had been validly tendered for purchase pursuant to the Offer.

The Company announces that it has decided to set the Final Acceptance Amount at EUR215,600,000 in aggregate nominal amount of Notes. Accordingly, the Company will accept for purchase all Notes validly tendered pursuant to the Offer with no pro rata scaling.

A summary of the results of the Offer appears below:

 
   Description     ISIN / Common   Final Acceptance 
   of the Notes         Code            Amount        Scaling Factor   Purchase Price 
----------------  --------------  -----------------  ---------------  --------------- 
 EUR750,000,000    XS1032164607     EUR215,600,000         N/A           104.60 per 
  2.50 per cent.    / 103216460                                             cent. 
  Notes due 2021

The Settlement Date in respect of those Notes accepted for purchase is expected to be 22 January 2019. Following settlement of the Offer, EUR534,400,000 in aggregate nominal amount of the Notes will remain outstanding.

Barclays Bank PLC (Telephone: +44 20 3134 8515; Attention: Liability Management Group; Email: eu.lm@barclays.com) and Citigroup Global Markets Limited (Telephone: +44 20 7986 8969; Attention: Liability Management Group; Email: liabilitymanagement.europe@citi.com) are acting as Dealer Managers for the Offer and Lucid Issuer Services Limited (Telephone: +44 20 7704 0880; Attention: David Shilson; Email: urenco@lucid-is.com) is acting as Tender Agent.

This announcement is released by the Company and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR), encompassing information relating to the Offer described above. For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Gerard Tyler, Head of Group Treasury at Urenco Limited.

LEI Number: 549300424FNJMWD3CO80

DISCLAIMER This announcement must be read in conjunction with the Tender Offer Memorandum. No offer or invitation to acquire any securities is being made pursuant to this announcement. The distribution of this announcement and the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Tender Offer Memorandum comes are required by each of the Company, the Dealer Managers and the Tender Agent to inform themselves about, and to observe, any such restrictions.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RTEEAEFXFEANEFF

(END) Dow Jones Newswires

January 17, 2019 05:03 ET (10:03 GMT)

Urenco 24 (LSE:44ZP)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024